Top Markets
#1 MowCat MowCat +49.00%
#2 Velvet Velvet +25.26%
#3 Audiera Audiera +25.23%
#4 Bermuda Shorts Bermuda Shorts +24.30%
#5 Quack AI Quack AI +21.46%
#6 Derive Derive +18.79%
#7 aPriori aPriori +17.89%
#8 Biconomy Biconomy +16.63%
#9 SkyAI SkyAI +14.17%
#10 Geodnet Geodnet +13.59%
Coin of the day
MowCat MowCat
設定
言語
日本
通貨
USD
テーマ
Graybug Vision, Inc. Graybug Vision, Inc.

Graybug Vision, Inc.

GRAY
株式のランク #35305
Graybug Vision, Inc. is a biopharmaceutical company currently in its clinical... Graybug Vision, Inc. is a biopharmaceutical company currently in its clinical development phase, dedicated to creating treatments for conditions affecting the eye's retina and optic nerve. Its flagship therapeutic, GB-102, is an injectable microparticle formulation of sunitinib administered directly into the eye. This compound is progressing through Phase I/IIa and IIb clinical trials for wet age-related macular degeneration, while also undergoing Phase IIa trials for diabetic macular edema. Furthermore, GB-102 is being explored as a treatment for diabetic retinopathy. The company's pipeline also includes GB-401, an intraocular implant designed to deliver a beta-adrenergic receptor inhibitor, intended for the management of primary open-angle glaucoma. Initially established as Graybug LLC in 2011, the firm rebranded to Graybug Vision, Inc. in 2016 and is headquartered in Redwood City, California.
株価
$2.70
最終同期: 2023-05-17
時価総額
$4.13M
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Graybug Vision, Inc. (GRAY)

カテゴリー

Healthcare
Graybug Vision, Inc.（GRAY）の配当履歴
Graybug Vision, Inc.（証券コード：GRAY）は合計で0回の配当を行いました。
すべての配当の合計（株式分割調整済み）は：0.00
配当利回り（TTM）：0
2026から2026までのGraybug Vision, Inc.（GRAY）の配当履歴
年間配当支払い
年 配当（株式分割調整済み） 変化
提供された日付のデータは十分ではありません。
すべての配当支払いの一覧
年 配当 変化
提供された日付のデータは十分ではありません。
同業他社や競合企業の配当履歴
企業 配当支払い回数 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
29.00%
BE